Steve Gorlin - Nov 9, 2023 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role: Director
Signature: /S/ STEVE GORLIN
Stock symbol: BIVI
Transactions as of: Nov 9, 2023
Transactions value $: -$127,899
Form type: 4
Date filed: 12/6/2023, 04:16 PM
Previous filing: Sep 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIVI	Common Stock	Award	$0	+46.4K	+61.26%	$0.00	122K	Nov 9, 2023	Direct	F1
transaction	BIVI	Common Stock	Sale	-$128K	-75.7K	-62.01%	$1.69	46.4K	Dec 1, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting.

Content

The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting.